DUBLIN–(BUSINESS WIRE)–The “Global Contact Lenses Mask Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering. The Global Contact Lenses Market size is expected to reach $18 billion by 2024, rising at a market growth …
Author: Business Wire
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra® (tocilizumab)…
Vivior Signs Agreement with Kochoptik to Evaluate Vivior’s System
ZURICH–(BUSINESS WIRE)–Vivior has signed an agreement with Kochoptik, a premium optical retailer in Switzerland. Kochoptik’s customers will wear Vivior’s Visual Behavior Monitor to provide a recommendation for an individualized vision care solution. …
Presbia to Participate in the XXXVI Congress of the European Society of Cataract & Refractive Surgeons and in the German Ophthalmological Society Congress
DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ:LENS), an ophthalmic device company and leader in near-vision restoration, will participate in the XXXVI Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), Europe’s leading organiz…
Travecta Therapeutics Appoints Douglas C. Hicks as Chief Business Officer
PHILADELPHIA–(BUSINESS WIRE)–Travecta Therapeutics, an emerging biotech company developing a platform that leverages its proprietary knowledge of the MFSD2a Transport for the targeted delivery of therapeutic agents across the blood-brain barrier, ann…
Paragon BioTeck Reformulated FRESHKOTE®, Prompting Eyevance Acquisition
PORTLAND, Ore.–(BUSINESS WIRE)–Paragon BioTeck, recently completed the reformulation for FRESHKOTE® lubricant eye drops, purchased this week by Eyevance Pharmaceuticals.
Aerie Pharmaceuticals to Present at Ophthalmology Futures Forums in Vienna, Austria
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
The Global Eyewear Market with Focus on Premium Eyewear (2018-2022) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eyewear Market with Focus on The Premium Eyewear (2018-2022 Edition)” report has been added to ResearchAndMarkets.com’s offering. The global eyewear market has increased with a healthy growth rate over the years and…
More than 180 Children’s Hospital Los Angeles Physicians Named “Top Doctors” in Annual List Honoring the Region’s Most Esteemed Specialists
LOS ANGELES–(BUSINESS WIRE)–More than 180 Children’s Hospital Los Angeles physicians were named Top Doctors by Pasadena Magazine, honoring the region’s most esteemed specialists.
In Australia, NovaTears® Eye Drops Are Available on the Pharmaceutical Benefits Scheme (PBS) from Now On
HEIDELBERG, Germany–(BUSINESS WIRE)–#AFT–Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, is the manufacturer of NovaTe…
STAAR Surgical Announces EVO ICL Clinical Program for its 15th Annual Surgical Experts Summit in Vienna, Austria, from September 19 – 21, 2018
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing the EVO ICL Clinical Program which will be pr…
The $65.25Bn Global Ophthalmic Devices Market to 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Market – Forecasts from 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering. The ophthalmic device market is projected to grow at a CAGR of 5.01% to reach US$65.248 billion in 2023 f…
Uveitis – Epidemiology Forecast to 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Uveitis – Epidemiology Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. Uveitis – Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Uveitis in seven major markets (…
Global Conjunctivitis Drugs Market 2018-2024 – Increasing Clinical Trials & Rising Prevalence of Bacterial Conjunctivitis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Conjunctivitis Drugs Market 2018-2024” report has been added to ResearchAndMarkets.com’s offering. The Global Bacterial Conjunctivitis Drugs Market is estimated to witness a CAGR of 2.1% during the forecast period 2…
Minnetronix Announces Rebrand to Minnetronix Medical
ST. PAUL, Minn.–(BUSINESS WIRE)–Minnetronix, Inc., a leading medical technology and solutions provider, today announced that it has rebranded as Minnetronix Medical, Inc.
Aerie Pharmaceuticals Announces Appointment of Thomas A. Shepard as Vice President, Implant Manufacturing
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced the appointment of Thomas A. Shepard as Vice President, Implant Manufacturing, reporting to Casey Kopczynski, Ph.D., Aerie’s Chief Scientific Officer. Mr. Shepard will lead Aerie’s
New Jersey Children Receive Free Comprehensive Eye Exams and Prescription Glasses as Part of Back-to-School Health Event
NEWARK, N.J.–(BUSINESS WIRE)–Newark-area Boys & Girls Club children received free eye exams and glasses as part of an event organized by UnitedHealthcare and Eye Care 4 Kids.
Retinitis Pigmentosa (Retinitis) – 2018 Pipeline Insights – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinitis Pigmentosa (Retinitis) – Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report offers comprehensive insights of the pipeline (under development) therapeutics scen…
Global Eyewear Market by Product Type, Lens Material, End User, Distribution Channel and Geography – Forecast to 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eyewear Market – Segmented by Product Type, Lens Material, End User, Distribution Channel and Geography – Growth, Trends and Forecasts (2018 – 2023)” report has been added to ResearchAndMarkets.com’s offering. The g…
Swiss Advanced Vision上市Harmonis – 首款用於白內障手術的可客製EDOF人工水晶體
瑞士納沙泰爾–(BUSINESS WIRE)–(美國商業資訊) — Swiss Advanced Vision (SAV-IOL)宣布上市Harmonis上市，這是一種用於白內障手術的可客製人工水晶體(IOL)，具有先進的延伸景深(EDOF)光學技術。眼科醫師有史以來第一次能夠在手術之前用一個Web介面的配置器將人工水晶體的各項光學參數調校至最佳水準，以適配所期望的視力結果。SAV-IOL將在9月21-25日於維也納召開的歐洲白內障和屈光外科醫師協會(ESCRS)第36屆年會期間向市場發布Harmonis。 為了使眼外科醫師及其患者獲得最佳視力，Harmonis Web介面的配置器可針對近距、中距和遠距視力的光分布比率、閱讀距離(Add)和 延伸景深(EDOF)提供一套可選擇的參數，形成合計超過3,000種的光學配置。 Harmonis與SAV-IOL現有的Eden和Lucidis人工水晶體產品陣容一起，向眼外科醫師提供了一系列用於白內障手術的優質、平價、精良、如今可客製的EDOF水晶體。所有三款產品的製造均採用公司獲得專利的瞬間聚焦光學技術，旨在延伸人工水晶體的景深，向患者提